Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: discordant responses to IL-6.
The rat serine protease inhibitor (Spi) 2 gene family includes both positive (Spi 2.2) and negative (Spi 2.1) acute phase reactants, facilitating modeling of regulation of hepatic acute phase response (APR). To examine the role of signal transducer and activation of transcription (STAT) proteins in the divergent regulation of these model genes after induction of APR, we evaluated the proximal promoters of the genes, focusing on STAT binding sites contained in these promoter elements. Induction of APR by turpentine injection includes activation of a STAT3 complex that can bind to a gamma-activated sequence (GAS) in the Spi 2.2 gene promoter, although the Spi 2.2 GAS site can bind STAT1 or STAT5 as well. To create an in vitro model of APR, primary hepatocytes were treated with combinations of cytokines and hormones to mimic the hormonal milieu of the whole animal after APR induction. Incubation of primary rat hepatocytes with interleukin (IL)-6, a critical APR cytokine, leads to activation of STAT3 and a 28-fold induction of a chloramphenicol acetyltransferase reporter construct containing the -319 to +85 region of the Spi 2.2 promoter. This suggests the turpentine-induced increase of Spi 2.2 is mediated primarily by IL-6. In contrast, although turpentine treatment reduces Spi 2.1 mRNA in vivo and IL-6 does not increase Spi 2.1 mRNA in primary rat hepatocytes, treatment of hepatocytes with IL-6 results in a 5. 4-fold induction of Spi 2.1 promoter activity mediated through the paired GAS elements in this promoter. Differential regulation of Spi 2.1 and 2.2 genes is due in part to differences in the promoters of these genes at the GAS sites. IL-6 alone fails to reproduce the pattern of rat Spi 2 gene expression that results from turpentine-induced inflammation.
Berry
S A
SA
Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Bergad
P L
PL
Stolz
A M
AM
Towle
H C
HC
Schwarzenberg
S J
SJ
D000210:Acute-Phase Reaction / Q000139:chemically induced / Q000503:physiopathology; D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism / Q000502:physiology; D005786:Gene Expression Regulation / Q000502:physiology*; D007249:Inflammation / Q000139:chemically induced / Q000235:genetics*; D015850:Interleukin-6 / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism; D008297:Male; D009687:Nuclear Proteins / Q000235:genetics*; D010902:Pituitary Gland / Q000502:physiology; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D050796:STAT3 Transcription Factor; D015843:Serpins / Q000235:genetics*; D015534:Trans-Activators / Q000378:metabolism / Q000502:physiology; D014425:Turpentine / Q000494:pharmacology
D004268:DNA-Binding Proteins; D015850:Interleukin-6; C091103:LOC299282 protein, rat; D009687:Nuclear Proteins; D012333:RNA, Messenger; D050796:STAT3 Transcription Factor; D015843:Serpins; C494088:Stat3 protein, rat; D015534:Trans-Activators; D014425:Turpentine